Cooperation between somatic Ikaros and Notch1 mutations at the inception of T-ALL

被引:2
作者
Sontani, Yovina [1 ]
Chapman, Gavin [3 ,4 ]
Papathanasiou, Peter [2 ]
Dunwoodie, Sally [3 ,4 ,5 ]
Goodnow, Christopher C. [1 ]
Hoyne, Gerard F. [1 ]
机构
[1] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canberra, ACT 2601, Australia
[2] Australian Natl Univ, Australian Phen Facil, Canberra, ACT 2601, Australia
[3] Victor Chang Cardiac Res Inst, Dev Biol Program, Sydney, NSW, Australia
[4] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia
[5] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
Ikaros; Leukemia; Notch; Thymocytes; T cell; ACUTE LYMPHOBLASTIC-LEUKEMIA; GAMMA-SECRETASE INHIBITORS; GENE-EXPRESSION; CELL LEUKEMIA; SIGNALING PATHWAY; ACTIVATION; EVENT; LEUKEMOGENESIS; MICE; MUTAGENESIS;
D O I
10.1016/j.leukres.2011.07.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To understand the interactions between Notch1 and Ikaros in the evolution of T cell acute lymphoblastic leukemia (T-ALL), we traced the evolution of T-ALL in mice with an inherited Ikaros mutation, Ikzf1(Plstc) which inactivates DNA binding. DNA-binding Ikaros repressed Notch1 response in transfected cell lines and in CD4(+)8(+) (DP) thymocytes from young pre-leukemic Ikzf1(Plstc) heterozygous mice. In DP thymocytes, a 50-1000 fold escalation in mRNA for Notch1 target genes Hes1 and Dtx1 preceded thymic lymphoma or leukemia and was closely correlated with the first detectable differentiation abnormalities, loss of heterozygosity (LOH) eliminating wild-type Ikzf1, and multiple missense and truncating Notch1 mutations. These findings illuminate the early stages of leukemogenesis by demonstrating progressive exaggeration of Notch1 responsiveness at the DP thymocyte stage brought about by multiple mutations acting in concert upon the Notch1 pathway. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1512 / 1519
页数:8
相关论文
共 50 条
  • [41] NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263
    Dastur, Anahita
    Choi, Ahyun
    Costa, Carlotta
    Yin, Xunqin
    Williams, August
    McClanaghan, Joseph
    Greenberg, Max
    Roderick, Justine
    Patel, Neha U.
    Boisvert, Jessica
    McDermott, Ultan
    Garnett, Mathew J.
    Almenara, Jorge
    Grant, Steven
    Rizzo, Kathryn
    Engelman, Jeffrey A.
    Kelliher, Michelle
    Faber, Anthony C.
    Benes, Cyril H.
    CLINICAL CANCER RESEARCH, 2019, 25 (01) : 312 - 324
  • [42] Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL
    Tottone, Luca
    Zhdanovskaya, Nadezda
    Pestana, Alvaro Carmona
    Zampieri, Michele
    Simeoni, Fabrizio
    Lazzari, Sara
    Ruocco, Valeria
    Pelullo, Maria
    Caiafa, Paola
    Felli, Maria Pia
    Checquolo, Saula
    Bellavia, Diana
    Talora, Claudio
    Screpanti, Isabella
    Palermo, Rocco
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [43] Novel oncogenic noncoding mutations in T-ALL
    Goossens, Steven
    Van Vlierberghe, Pieter
    BLOOD, 2017, 129 (24) : 3140 - 3142
  • [44] High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling
    Medyouf, Hind
    Gusscott, Samuel
    Wang, Hongfang
    Tseng, Jen-Chieh
    Wai, Carol
    Nemirovsky, Oksana
    Trumpp, Andreas
    Pflumio, Francoise
    Carboni, Joan
    Gottardis, Marco
    Pollak, Michael
    Kung, Andrew L.
    Aster, Jon C.
    Holzenberger, Martin
    Weng, Andrew P.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (09) : 1809 - 1822
  • [45] NOTCH1/PI3K信号通路在T-ALL治疗中的研究进展
    汤煜媛
    李翔鹏
    黄羽
    李彩霞
    医学综述, 2016, 22 (05) : 877 - 881
  • [46] Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL
    Antoszewski, Mateusz
    Fournier, Nadine
    Buendia, Gustavo A. Ruiz
    Lourenco, Joao
    Liu, Yuanlong
    Sugrue, Tara
    Dubey, Christelle
    Nkosi, Marianne
    Pritchard, Colin E. J.
    Huijbers, Ivo J.
    Segat, Gabriela C.
    Alonso-Moreno, Sandra
    Serracanta, Elisabeth
    Belver, Laura
    Ferrando, Adolfo A.
    Ciriello, Giovanni
    Weng, Andrew P.
    Koch, Ute
    Radtke, Freddy
    BLOOD, 2022, 139 (16) : 2483 - 2498
  • [47] Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond
    Pozzo, Federico
    Bittolo, Tamara
    Tissino, Erika
    Zucchetto, Antonella
    Bomben, Riccardo
    Polcik, Laura
    Dannewitz Prosseda, Svenja
    Hartmann, Tanja Nicole
    Gattei, Valter
    CANCERS, 2022, 14 (12)
  • [48] Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration
    Bhavsar, P. J.
    Infante, E.
    Khwaja, A.
    Ridley, A. J.
    ONCOGENE, 2013, 32 (02) : 198 - 208
  • [49] Notch1 Mutations Are Drivers of Oral Tumorigenesis
    Izumchenko, Evgeny
    Sun, Kai
    Jones, Sian
    Brait, Mariana
    Agrawal, Nishant
    Koch, Wayne
    McCord, Christine L.
    Riley, David R.
    Angiuoli, Samuel V.
    Velculescu, Victor E.
    Jiang, Wei-Wen
    Sidransky, David
    CANCER PREVENTION RESEARCH, 2015, 8 (04) : 277 - 286
  • [50] IL-15 Prevents the Development of T-ALL from Aberrant Thymocytes with Impaired DNA Repair Functions and Increased NOTCH1 Activation
    Nandi, Madhuparna
    Ghosh, Amit
    Akbari, Sara Ali
    Bobbala, Diwakar
    Boucher, Marie-Josee
    Menendez, Alfredo
    Hoang, Trang
    Ilangumaran, Subburaj
    Ramanathan, Sheela
    CANCERS, 2023, 15 (03)